期刊文献+

初诊Graves甲亢合并肝损害及其影响因素的临床分析 被引量:5

Clinical study of hepatic dysfunction and its correlative factors in newly diagnosed patients with Graves hyperthyroidism
原文传递
导出
摘要 目的 探讨初诊Graves甲状腺功能亢进症(简称甲亢)合并肝损害的发生率、临床特点及其相关因素.方法 回顾性分析初诊Graves甲亢患者204例,根据肝功能是否异常分为肝损害组146例和正常组58例.比较两组患者性别组成、年龄、甲状腺质量、病程、24 h摄131I率、游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、促甲状腺激素受体抗体(TRAb)、甲状腺过氧化物酶抗体(TPOAb)及甲状腺球蛋白抗体(TGAb)之间的差异,并对肝功能指标与甲状腺激素进行相关性分析.结果 ①初诊Graves甲亢合并肝损害(至少有一项肝功能指标异常)的发生率为71.6%,以谷丙转氨酶(ALT)异常最常见,发生率为37.7%;肝损害组中仅一项指标异常者61例(41.8%),以碱性磷酸酶(ALP)异常最常见,占50.8%(31/61).②肝损害组较正常组病程长,血FT3、FT4及TRAb水平明显增高,而两组间性别组成、年龄、甲状腺质量、24 h摄131I率、TPOAb、TGAb比较差异无统计学意义.③谷草转氨酶与FT3,ALP与FT3、FT4,总胆红素与FT4,直接胆红素与FT3、FT4均呈正相关.结论 初诊Graves甲亢合并肝损害的发生率较高,肝损害最常见的指标包括ALT、ALP水平异常,其发生与甲亢病程、甲状腺激素及TRAb水平密切相关. Objective To investigate the incidence,clinical features and the possible risk factors of hepatic dysfunction in the newly diagnosed patients with Graves hyperthyroidism.Methods A retrospective analysis about total 204 newly diagnosed patients with Graves hyperthyroidism was studied.All the patients were divided into two groups by liver function:the hepatic dysfunction group (146 cases)and the normal group (58 cases).The gender composition,age,thyroid weight,24 h-131I intake rate,free triiodothyronine (FT3),free thyronine (FT4),thyroid-stimulating hormone receptor antibody (TRAb),thyroid peroxidase antibodies (TPOAb)and thyroglobulin antibody (TGAb)were compared between the two groups.A correlation analysis was progressed between the indicators of liver function and thyroid hormone.Results ①The incidence of hepatic dysfunction (at least one abnormal parameter)in the newly diagnosed patients with Graves hyperthyroidism was 71.6% and the most familiar abnormal parameter was alanine transaminase (ALT) (37.7 %).Altogether 61 patients (41.8 %)had only one abnormal parameter in the hepatic dysfunction group and the most common abnormal parameter was alkaline phosphatase (ALP)(50.8%).②Compared with the normal group,hepatic dysfunction group had longer disease duration,higher serum FT3,FT4 and TRAb levels,but there were no significant differences in gender composition,age,thyroid weight,24 h-1nI intake rate,TPOAb,TGAb between the two groups.③A significantly positive correlation was found between the aspartate aminotransferase and FT3,the ALP and FT3,FT4,the total bilirubin and FT4,the direct bilirubin and FT3,FT4,respectively.Conclusions Hepatic dysfunction in newly diagnosed patients with Graves hyperthyroidism is very common and the most common abnormal parameters include ALT and ALP.The hepatic dysfunction is closely correlated with patients' disease duration,thyroid hormone and TRAb levels.
出处 《国际放射医学核医学杂志》 2013年第5期283-286,共4页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 格雷夫斯病 甲状腺功能亢进症 甲状腺激素类 肝功能 Graves disease Hyperthyroidism Thyroid hormones Hepatic function
  • 相关文献

参考文献11

  • 1姜艳,郭晖,潘润铎,姜宏.甲状腺功能亢进症初诊患者肝功能异常的临床分析[J].临床肝胆病杂志,2005,21(6):350-351. 被引量:12
  • 2Kubota S, Amino N, Matsumoto Y, et al. Serial changes in liverfunction tests in patients with thyrotoxicosis induced by Graves,disease and painless thyroiditis. Thyroid, 2008, 18(3) : 283-287.
  • 3田竹芳,施秉银,赵新,高珊,胡文华.Graves病患者甲亢性肝损害及其相关因素分析[J].西安交通大学学报(医学版),2010,31(2):205-207. 被引量:43
  • 4Sarinnapakorn V, Noppavetchwich P, Sunthorntepwarakul T, et al.Abnormal liver function test in Graves" disease : a prospectivestudy of comparison between the hyperthyroid state and theeuthyroid state. J Med Assoc Thai, 2011, 94 Suppl 2; SI 1-16.
  • 5O' Brian CJ, Macchia E, Cundy TF, et al. Patterns of cellularimmune responses to thyrocyte membrane antigens and specificimmunoregulatory defects in autoimnune thyroid disease. J ClinLab Immunol, 1990, 32(3): 103-108.
  • 6Woeber KA. Methimazole-induced hepatotoxicity. Endocr Pract,2002,8(3): 222-224.
  • 7任留梅,刘萍,卫红艳,邱明才.Graves病甲亢肝损害与免疫因素关系的探讨[J].实用医学杂志,2011,27(3):436-438. 被引量:20
  • 8中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. 被引量:846
  • 9Agretti P, Chiovato L, De Marco G, et al. Real-time PCR providesevidence for thyrotropin receptor mRNA expression in orbital aswell as in extraorbital tissues. Eur J Endocrinol, 2002, 147 (6):733-739.
  • 10Zhang W, Tian LM, Han Y, et al. Presence of thyrotropin receptorin hepatocytes : not a case of illegitimate transcription. J Cell MolMed,2009, 13(11-12): 4636-4642.

二级参考文献39

共引文献909

同被引文献39

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部